Lisa Stockman-Mauriello is dying from ALS, but a pharmaceutical company, Biogen, is trialing a new drug called Torfersen that may buy her a little extra time.
Masks need to be more efficient, and therein lies the rationale for double masking. Increased transmissibility in new variants should be all the justification we need.
If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.
They collect your DNA with every swab, and it’s sent to a laboratory for analysis. Then where does that sample go, and who has access to the data extracted? Not you.
